A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome

Leukemia Research

Volumn 34, Issue 12, 2010, Pages 1566-1572

  Vasikova, Alzbeta ^a   Belickova, Monika ^a   Budinska, Eva ^b   Cermak, Jaroslav ^a,c  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute myeloid leukemia; CD34+ cells; Gene expression profiling; Microarray; Myelodysplastic syndrome

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANGPT GENE; ARTICLE; CD34 SELECTION; CELL CYCLE REGULATION; CONTROLLED STUDY; CYBRD1 GENE; DISEASE ACTIVITY; DNA REPAIR; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; HBG1 GENE; HBG2 GENE; HSPA1B GENE; HUMAN; HUMAN TISSUE; LYMPHOPOIESIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PRIORITY JOURNAL; PROTO ONCOGENE; UPREGULATION;

ADULT; AGED; ANGIOPOIETIN-1; ANTIGENS, CD34; APOPTOSIS; CELL CYCLE; CYTOCHROME B GROUP; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; ONCOGENE PROTEIN P55(V-MYC); OXIDOREDUCTASES;

EID: 77957162079     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.02.021     Document Type: Article

References (32)

1. Cazzola M., Malcovati L. Myelodysplastic syndromes-coping with ineffective hematopoiesis. N Engl J Med 2005, 352:536-538.
2. Aul C., Germing U., Gattermann N., Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious?. Leuk Res 1998, 22:93-100.
3. Nolte F., Hofmann W.K. Myelodysplastic syndromes: molecular pathogenesis and genomic changes. Ann Hematol 2008, 87:777-795.
4. Miyazato A., Ueno S., Ohmine K., Ueda M., Yoshida K., Yamashita Y., et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 2001, 98:422-427.
5. Hofmann W.K., de Vos S., Komor M., Hoelzer D., Wachsman W., Koeffler H.P. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 2002, 100:3553-3560.
6. Ueda M., Ota J., Yamashita Y., Choi Y.L., Ohki R., Wada T., et al. DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome. Br J Haematol 2003, 123:288-296.
7. Pellagatti A., Cazzola M., Giagounidis A.A., Malcovati L., Porta M.G., Killick S., et al. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood 2006, 108:337-345.
8. Boultwood J., Pellagatti A., Cattan H., Lawrie C.H., Giagounidis A., Malcovati L., et al. Gene expression profiling of CD34+ cells in patients with the 5q-syndrome. Br J Haematol 2007, 139:578-589.
9. Chomczynsky P., Sacchi N. Single step method of RNA isolation by acid quanidin-isothiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
10. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
11. Ballman K.V. Genetics and genomics. Statistical primer for cardiovascular research. Circulation 2008, 118:1593-1597.
12. Iwasaki T., Murakami M., Sugisaki C., Sobue S., Ohashi H., Asano H., et al. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia. Pathol Int 2008, 58:353-360.
13. Choi J.W., Kim Y., Fujino M., Ito M. Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes. Leukemia 2002, 16:1478-1483.
14. Pradhan A., Mijovic A., Mills K., Cumber P., Westwood N., Mufti G.J., et al. Differentially expressed genes in adult familial myelodysplastic syndromes. Leukemia 2004, 18:449-459.
15. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 2000, 86:24-29.
16. Albitar M. Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome. Acta Haematol 2001, 106:170-176.
17. Hou H.A., Chou W.C., Lin L.I., Tang J.L., Tseng M.H., Huang C.F., et al. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Leuk Res 2008, 32:904-912.
18. Dominguez-Sola D., Ying C.Y., Grandori C., Ruggiero L., Chen B., Li M., et al. Non-transcriptional control of DNA replication by c-myc. Nature 2007, 448:445-451.
19. Hirvonen H., Hukkanen V., Salmi T.T., Pelliniemi T.T., Alitalo R. L-myc and N-myc in hematopoietic malignancies. Leuk Lymphoma 1993, 11:197-205.
20. Sawyers C.L. The role of myc in transformation by BCR-ABL. Leuk Lymphoma 1993, 11(Suppl. 1):45-46.
21. Larramendy M.L., Niini T., Elonen E., Nagy B., Ollila J., Vihinen M., et al. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis. Haematologica 2002, 87:569-577.
22. Fuhrken P.G., Chen C., Apostolidis P.A., Wang M., Miller W.M., Papoutsakis E.T. Gene ontology-driven transcriptional analysis of CD34+ cell-initiated megakaryocytic cultures identifies new transcriptional regulators of megakaryopoiesis. Physiol Genom 2008, 33:159-169.
23. Li Q.X., Ke N., Sundaram R., Wong-Staal F. NR4A1, 2, 3-an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 2006, 21:533-540.
24. Sternberg A., Killick S., Littlewood T., Hatton C., Peniket A., Seidl T., et al. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood 2005, 106:2982-2991.
25. Huang W., Zhu C., Wang H., Horvath E., Eklund E.A. The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells. J Biol Chem 2008, 283:7921-7935.
26. Wang H., Lee C.H., Qi C., Tailor P., Feng J., Abbasi S., et al. IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 2008, 112:4028-4038.
27. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423:255-260.
28. Mihara K., Chowdhury M., Nakaju N., Hidani S., Ihara A., Hyodo H., et al. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood 2006, 107:305-308.
29. Keating A.K., Salzberg D.B., Sather S., Liang X., Nickoloff S., Anwar A., et al. Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene 2006, 25:6092-6100.
30. Graham D.K., Salzberg D.B., Kurtzberg J., Sather S., Matsushima G.K., Keating A.K., et al. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. Clin Cancer Res 2006, 12:2662-2669.
31. Medeiros R.B., Burbach B.J., Mueller K.L., Srivastava R., Moon J.J., Highfill S., et al. Regulation of NF-kappaB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science 2007, 316:754-758.
32. Habib G.M., Shi Z.Z., Cuevas A.A., Lieberman M.W. Identification of two additional members of the membrane-bound dipeptidase family. FASEB J 2003, 17:1313-1315.